| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ad23ecf473f76fdb0ed90e87ed0e312f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13fddbe58aa7ad914384c68738a6833c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-15
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-37
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 |
| filingDate |
2019-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef86db907ba1316d733c6bf821da61b9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1034786ac0e569a831b8a96ecf92dc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_037cd4297170a5d8e6f7f914e3ef8aac |
| publicationDate |
2019-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019163684-A1 |
| titleOfInvention |
Anticancer agent |
| abstract |
Provided is an anticancer agent that has a novel function based on a novel mechanism. Also provided is a novel anticancer agent that has a function of suppressing cancer stem cell properties and/or a function of suppressing cancer cell proliferation. Also provided is a method for screening a novel anticancer agent. The anticancer agent comprises as an active ingredient a substance having an anti-adipsin function. The anticancer agent according to the present invention, which comprises as an active ingredient a substance having an anti-adipsin function, has functions of suppressing cancer stem cell properties and suppressing cancer cell proliferation. The antitumor function based on the suppression of adipsin is a novel mechanism. Therefore, a novel anticancer agent can be screened by focusing on this function mechanism. Thus, a more efficacious anticancer agent capable of suppressing cancer stem cell properties can be acquired. |
| priorityDate |
2018-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |